Request for Information; Reopening of Comment Period

Issuing agencies

Abstract

The Office of Management and Budget (OMB) published in the Federal Register a request for information (RFI) regarding new and unused (idle) domestic, U.S.-based, and near shore production capabilities for Finished Dose Forms, Active Pharmaceutical Ingredients, and Key Starting Materials associated with the Administration for Strategic Preparedness and Response (ASPR) 86 List of essential medicines. The RFI provided for a 30-day response period which closed on October 26, 2026. OMB has determined that reopening the comment period until November 27, 2026, is appropriate. This action will allow interested parties additional time to prepare information and responses.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 210 (Monday, November 2, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 210 (Monday, November 2, 2026)]
[Notices]
[Page 68988]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-22328]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF MANAGEMENT AND BUDGET


Request for Information; Reopening of Comment Period

AGENCY: Office of Management and Budget.

ACTION: Request for information; reopening of response period.

-----------------------------------------------------------------------

SUMMARY: The Office of Management and Budget (OMB) published in the 
Federal Register a request for information (RFI) regarding new and 
unused (idle) domestic, U.S.-based, and near shore production 
capabilities for Finished Dose Forms, Active Pharmaceutical 
Ingredients, and Key Starting Materials associated with the 
Administration for Strategic Preparedness and Response (ASPR) 86 List 
of essential medicines. The RFI provided for a 30-day response period 
which closed on October 26, 2026. OMB has determined that reopening the 
comment period until November 27, 2026, is appropriate. This action 
will allow interested parties additional time to prepare information 
and responses.

DATES: The response period for the notice published on September 25, 
2026 (91 FR 60983), regarding the RFI on Domestic and Near Shore 
Manufacturing of Essential Medicines on the ASPR 86 List, is reopened. 
Responses must be received on or before November 27, 2026.

ADDRESSES: Responses must be submitted electronically through 
<a href="http://regulations.gov">regulations.gov</a>. Mailed paper submissions will not be accepted, and 
electronic submissions received after the deadline may not be 
considered.
    Instructions: Federal eRulemaking Portal: Go to <a href="http://www.regulations.gov">www.regulations.gov</a> 
search ``Domestic and Near Shore Manufacturing of Essential Medicines 
RFI'' to submit your comments electronically. Information on how to use 
Regulations.gov, including instructions for accessing agency documents, 
submitting comments, and viewing the docket, is available on the site 
under ``FAQ'' (<a href="https://www.regulations.gov/faq">https://www.regulations.gov/faq</a>). Should you choose to 
include proprietary information or confidential business information in 
your submission, please ensure you use appropriate markings and 
handling instructions to alert OMB as to the nature of information 
being submitted and maintain proper handling. Your response will be 
shared with other Federal agencies and entities.
    Privacy Act Statement: OMB is issuing this request for information 
(RFI) pursuant to its authorities under 31 U.S.C. 501 et seq. Comments 
and commenter information are maintained under the OMB Public Input 
System of Records, OMB/INPUT/01. The system of records notice 
accessible at 88 FR 20913 (<a href="https://www.federalregister.gov/documents/2023/04/07/2023-07452/privacy-act-of-1974-system-of-records">https://www.federalregister.gov/documents/2023/04/07/2023-07452/privacy-act-of-1974-system-of-records</a>) includes a 
list of routine uses associated with the collection of this 
information.
    Disclaimer: Participation in this RFI is strictly voluntary. OMB 
will use your feedback to inform sound decision-making on topics 
related to this RFI regarding potential government-wide actions to 
revitalize the domestic manufacturing base, create new opportunities 
for U.S. firms and workers, and position U.S. businesses to compete and 
lead globally in strategic industries. This announcement should not be 
construed as a commitment of any kind by the U.S. Government. The U.S. 
Government is in no way liable to pay for or reimburse any companies or 
entities that respond to this announcement. Nothing in this 
announcement constitutes an obligation on the part of the U.S. 
Government. A response to this RFI will not be viewed as a binding 
commitment to develop or pursue the project or ideas discussed.

FOR FURTHER INFORMATION CONTACT: Please direct questions regarding this 
Notice to Robert Orr, Deputy to the Associate Director of Economic 
Policy, Office of Management and Budget, tel: 202-395-1390, or email 
the Made in America Office at <a href="/cdn-cgi/l/email-protection#7c311d181935123d11190e151f1d3c13111e5219130c521b130a"><span class="__cf_email__" data-cfemail="115c707574587f507c7463787270517e7c733f747e613f767e67">[email&#160;protected]</span></a> with ``Domestic 
and Near Shore Manufacturing of Essential Medicines on the ASPR 86 
List'' in the subject line.

SUPPLEMENTARY INFORMATION: On September 25, 2026, OMB published in the 
Federal Register an RFI soliciting responses on new and unused (idle) 
domestic, U.S.-based, and near shore production capabilities for 
Finished Dose Forms, Active Pharmaceutical Ingredients, and Key 
Starting Materials associated with the ASPR 86 List of essential 
medicines. The RFI stated that the response period would close on 
October 26, 2026. OMB has received requests to reopen the response 
period. Reopening the response period will allow interested parties 
additional time to prepare information and comments. Therefore, OMB is 
reopening the response period for the RFI until November 27, 2026.

Michael Stumo,
Director, Made in America Office.
[FR Doc. 2026-22328 Filed 10-30-26; 8:45 am]
BILLING CODE 3110-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>